Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Crystal Haskell-Ramsay +44 191 2274875
crystal.haskell-ramsay@northumbria.ac.uk


Study Location:

Skip to Main Content

Information about our updated policies

Read our updated privacy notice and terms and conditions to see how your personal information might be used.

English | Cymraeg
Be Part of Research - Trial Details - 12-week Magnesium Supplementation on Peri-menopause Symptoms, Cognition, Sleep, and Psychological Well-being

12-week Magnesium Supplementation on Peri-menopause Symptoms, Cognition, Sleep, and Psychological Well-being

Recruiting

Open to: FEMALE

Age: 40.0 - 60.0

Medical Conditions

Perimenopause
Perimenopausal Women
Perimenopause, Climacteric Syndrome


This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


Perimenopause is a transition phase into menopause, characterised by menopausal symptoms while menstrual periods are still occurring. Common symptoms of perimenopause include hot flushes, night sweats, mood swings, anxiety, sleep disturbances, fatigue, and cognitive difficulties. These symptoms can be both frequent and intense, with the potential to significantly deteriorate women's quality of life. Despite an increase in public discourse around menopause, there are still large gaps in knowledge. Previous literature has suggested a relationship between diet and menopause management. However, studies in this area are limited and women often rely on social media for advice on supplements to address menopause complaints. One supplement that has received a lot of attention with purported benefits for menopause is magnesium, primarily due to its links to energy and or/sleep, however no studies have explored psychological effects of magnesium supplementation in perimenopause.

The aim of this study is to explore the effects of 12-weeks magnesium supplementation on perimenopause symptoms, cognition, sleep, and psychological well-being.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Dec 2025 Aug 2026

INTERVENTIONAL

Intervention Type : OTHER
Intervention Description : 12 week placebo supplement of 2 capsules per day

Intervention Arm Group : Placebo;

Intervention Type : DIETARY_SUPPLEMENT
Intervention Description : 12 week supplementation of 2 capsules per day of Magnesium hydroxide

Intervention Arm Group : 375mg magnesium hydroxide;



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • School of Psychology, Northumbria University
    Newcastle upon Tyne
    NE1 8ST


The study is sponsored by Northumbria University and is in collaboration with Vitabiotics.




We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details for Trial ID: NCT07235878
Last updated 28 May 2026

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.